Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.
Saved in:
| Title: | Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study. |
|---|---|
| Authors: | Friedman DN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA., Goodman PJ; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Leisenring WM; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Diller LR; Department of Pediatrics, The Dana-Farber Cancer Institute, Boston, MA, USA., Cohn SL; Department of Pediatrics, The University of Chicago, Chicago, IL, USA., Howell RM; Division of Radiation Oncology, Department of Radiation Physics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA., Smith SA; Division of Radiation Oncology, Department of Radiation Physics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA., Tonorezos ES; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA., Wolden SL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Neglia JP; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA., Ness KK; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Gibson TM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Nathan PC; Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada., Turcotte LM; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA., Weil BR; Department of Pediatrics, The Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Surgery, Boston Children's Hospital, Boston, MA, USA., Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Oeffinger KC; Department of Medicine, Duke Cancer Institute, Duke University, Durham, NC, USA., Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Sklar CA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA., Henderson TO; Department of Pediatrics, The University of Chicago, Chicago, IL, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jun 07; Vol. 116 (6), pp. 885-894. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
